In Vitro Diagnostics (IVD) include reagents, instruments, and systems intended for use in the diagnosis of disease or other conditions, including the determination of the state of health, in order to treat or prevent disease. The reagents, instruments and systems are intended for use in the collection, preparation, and examination of specimens taken from the human body. The categories tracked under this market are Cardiac Disease, Hematological Disorders, Hormonal Disorders, Metabolic Disorder, Infectious Disease, IVD Analyzers and Reagents, Oncology and Reproductive Health Diagnostics. Multi-parameter Chlamydia trachomatis and Neisseria gonorrhea (CT/NG) Nucleic Acid Amplification Tests (NAAT) are used to simultaneously detect both Chlamydia trachomatis and Neisseria gonorrhea from the same sample, providing convenience in screening and diagnosis. GlobalData uses proprietary data and analytics to provide a comprehensive report on the multi-parameter ct/ng naats devices market, including market shares of different players within the Netherlands. Buy the latest report here.
Smarter leaders trust GlobalData
In 2021, GlobalData’s Market Model methodology determined that the leading player in the multi-parameter ct/ng naats market in the Netherlands was Hologic followed by Danaher, F. Hoffmann-La Roche, Abbott Laboratories and Becton Dickinson and Co.
Multi-parameter Chlamydia trachomatis and Neisseria gonorrhea (CT/NG) Nucleic Acid Amplification combination test uses PCR or Ligase chain reaction methods to amplify nucleic acid sequences of C. trachomatis and N. gonorrhea, by targeting specific nucleic acid sequences. The process involves a polymerase chain reaction or ligase chain reaction with specific primers, nucleotide triphosphates, and taq polymerase leading to the production of detectable amounts of DNA or RNA. DNA or RNA is used as a template for transcription and reverse transcription reactions in series also known as transcription mediated amplification or nucleic acid sequence-based amplification.
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the multi-parameter ct/ng naats devices market within the Netherlands was expected to be over $7m in 2021.
For the latest complete market share analysis of multi-parameter ct/ng naats device market in the Netherlands, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
